CRIS Current Research Information System

BONIFAZI, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.198
EU - Europa 2.737
AS - Asia 1.323
AF - Africa 178
SA - Sud America 13
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.456
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.183
IT - Italia 765
GB - Regno Unito 487
SE - Svezia 439
SG - Singapore 410
CN - Cina 395
DE - Germania 305
VN - Vietnam 235
IN - India 137
UA - Ucraina 117
IE - Irlanda 115
RU - Federazione Russa 81
FR - Francia 79
TG - Togo 79
FI - Finlandia 70
AT - Austria 52
BG - Bulgaria 51
JO - Giordania 51
CH - Svizzera 47
CI - Costa d'Avorio 37
BE - Belgio 27
ZA - Sudafrica 27
EE - Estonia 24
NL - Olanda 22
NG - Nigeria 21
JP - Giappone 18
ID - Indonesia 17
CA - Canada 15
IR - Iran 11
HK - Hong Kong 10
HR - Croazia 8
SC - Seychelles 8
TR - Turchia 8
ES - Italia 7
BR - Brasile 6
CL - Cile 6
AU - Australia 5
DK - Danimarca 5
LT - Lituania 5
PT - Portogallo 5
RO - Romania 5
BD - Bangladesh 4
NO - Norvegia 4
PK - Pakistan 4
RS - Serbia 4
CZ - Repubblica Ceca 3
GR - Grecia 3
KE - Kenya 3
KR - Corea 3
LB - Libano 3
PH - Filippine 3
TW - Taiwan 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
LA - Repubblica Popolare Democratica del Laos 2
MY - Malesia 2
PL - Polonia 2
TZ - Tanzania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BY - Bielorussia 1
EC - Ecuador 1
HU - Ungheria 1
KW - Kuwait 1
LI - Liechtenstein 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UG - Uganda 1
Totale 7.456
Salva come PNG Salva come JPEG
Città #
Chandler 456
Southend 416
Singapore 370
Fairfield 300
Bologna 218
Ashburn 200
Ann Arbor 184
Dong Ket 172
Woodbridge 144
Wilmington 138
Seattle 137
Houston 124
Princeton 119
Dublin 114
Santa Clara 113
Boardman 99
Cambridge 83
Jacksonville 79
Lomé 79
New York 72
Helsinki 67
Amman 51
Sofia 51
Bremen 46
Beijing 45
Berlin 45
Bern 42
Nanjing 42
Milan 40
Westminster 40
Vienna 38
Abidjan 37
Florence 32
Turin 31
Padova 29
Brussels 27
Redmond 24
Saint Petersburg 24
San Diego 24
Hyderabad 22
Abeokuta 21
Rome 18
Hebei 16
Jakarta 16
Los Angeles 16
Jinan 15
Mülheim 14
Tokyo 14
Medford 12
Nanchang 12
Reggio Emilia 12
Guangzhou 11
Norwalk 11
Toronto 11
Verona 11
Redwood City 10
Amsterdam 9
Changsha 9
Forlì 9
Hong Kong 9
London 9
Modena 9
San Francisco 9
Zhengzhou 9
Haikou 8
Mahé 8
Paris 8
Pune 8
Shanghai 8
Taizhou 8
Chengdu 7
Hangzhou 7
Moscow 7
Ningbo 7
Olalla 7
Phoenix 7
Shenyang 7
Tianjin 7
Washington 7
Wuhan 7
Casalecchio di Reno 6
Des Moines 6
Falls Church 6
Ferrara 6
Jiaxing 6
Qingdao 6
Ravenna 6
Shenzhen 6
Bari 5
Calderara di Reno 5
Dearborn 5
Frankfurt am Main 5
Kunming 5
Mountain View 5
Munich 5
York 5
Andover 4
Dongguan 4
Foshan 4
Fukushima 4
Totale 4.888
Salva come PNG Salva come JPEG
Nome #
Acute graft-versus-host disease and steroid treatment impair CD11c+ and CD123+ dendritic cell reconstitution after allogeneic peripheral blood stem cell transplantation. 256
Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes 226
Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation 184
Allotransplant in relapsed or refractory aggressive T-cell lymphomas: retrospective monocentric analysis of 14 patients 182
Imatinib and pegylated human recombinant interferon-alpha2b in early chronic-phase chronic myeloid leukemia 175
Molecular response to imatinib in late chronic-phase chronic myeloid leukemia 169
Alemtuzumab in the treatment of relapsed acute lymphoid leukaemia. 166
Clinical utility of measuring Epstein-Barr virus-specific cell-mediated immunity after HSCT in addition to virological monitoring: results from a prospective study. 159
Higher numbers of blood CD14+ cells before starting conditioning regimen correlate with greater risk of acute graft-versus-host disease in allogeneic stem cell transplantation from related donors. 158
Digitisation of temporary exhibitions: the Aldrovandi case 154
Cryotherapy in the prevention of oral mucositis in patients receiving low-dose methotrexate following myeloablative allogeneic stem cell transplantation: a prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo nurses group. 154
Successful treatment of severe hemorrhagic cystitis with selective vesical artery embolization. 150
Glutathione transferase-A2 S112T polymorphism predicts survival, transplant-related mortality, busulfan and bilirubin blood levels after allogeneic stem cell transplantation 148
MEC (mitoxantrone, etoposide, and cytarabine) induces complete remission and is an effective bridge to transplant in acute myeloid leukemia 144
Successful management of EBV-PTLD in allogeneic bone marrow transplant recipient by virological-immunological monitoring of EBV infection, prompt diagnosis and early treatment. 141
Patterns of AML1-ETO transcript expression in patients with acute myeloid leukemia and t(8;21) in complete hematologic remission. 137
Phase II study of a single pegfilgrastim injection as an adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients. 136
Larger size of donor alloreactive NK cell repertoire correlates with better response to NK cell immunotherapy in elderly acute myeloid leukemia patients 135
Developing a new grading system of ocular surface disease after allogeneic hematopoietic stem cell transplantation (HSCT). 134
Slug/β-Catenin–Dependent Proinflammatory Phenotype in Hypoxic Breast Cancer Stem Cells 128
Cytomegalovirus and Epstein-Barr Virus DNA Kinetics in Whole Blood and Plasma of Allogeneic Hematopoietic Stem Cell Transplantation Recipients 127
In vivo T-cell depletion with low-dose ATG is effective in reducing cGVHD after peripheral blood stem cell myeloablative sibling transplants in CML: results from a prospective phase II study. 126
Effectiveness of Fludarabine, Idarubicin and Cyclophosphade (FLUIC) Combination Regimen for Young Patients with Untreated Non-Follicular Low-Grade Non-Hodgkin’s Lymphoma. 125
GVHD and prognostic factors. 125
Hairy Cell Leukemia: Allogeneic Transplantation Could be an Optimal Option in Selected Patients. 125
Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukemia 124
Eyelid metrics assessment in patients with chronic ocular graft versus-host disease 123
Autologous stem cell transplantation for acute myeloid leukemia patients in first complete remission: a 10-year follow-up study of 118 patients. 122
Low-Dose Anti-T Lymphoglobulin as Prophylaxis for Graft-versus-Host Disease in Unrelated Donor Transplantations for Acute Leukemias and Myelodysplastic Syndromes. 120
Intensification of GVHD prophylaxis with low-dose ATG-F before allogeneic PBSC transplantation from HLA-identical siblings in adult patients with hematological malignancies: results from a retrospective analysis 117
Role of imaging techniques in liver veno-occlusive disease diagnosis: recent advances and literature review 116
Stem cell mobilization and collection in patients with liver cirrhosis. 112
Successful treatment of disseminated Fusariosis after allogeneic hematopoietic stem cell transplantation with the combination of voriconazole and liposomal amphotericin B 107
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters 106
Effect on survival of the development of late-onset non-infectious pulmonarycomplications after stem cell transplantation. 105
The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma 102
Pre-transplant CD69+ extracellular vesicles are negatively correlated with active ATLG serum levels and associate with the onset of GVHD in allogeneic HSCT patients 92
Saprochaete clavata infections in patients undergoing treatment for haematological malignancies: A report of a monocentric outbreak and review of the literature 92
Peripheral blood cellular profile at pre-lymphodepletion is associated with {CD}19-targeted {CAR}-T cell-associated neurotoxicity 90
Validation of the New European LeukemiaNet (ELN) Recommendations for Bcr-Abl Kinase Domain Mutation Analysis In Chronic Myeloid Leukemia: An Analysis of the GIMEMA CML Working Party Studies 90
Assessment and prevention of cytomegalovirus infection in allogeneic hematopoietic stem cell transplant and in solid organ transplant: A multidisciplinary consensus conference by the Italian GITMO, SITO, and AMCLI societies. 90
null 86
Conjunctival epithelial cells (CEC) morphology in hematological patients before and after hematopoietic stem cell transplantation (HSCT). A Cytological and Confocal Microscopy Study 84
Molecular monitoring of BCR-ABL transcripts after allogeneic stem cell transplantation for chronic myeloid leukaemia 84
Meibomian Gland Dropout in Hematological Patients Prior to Hematopoietic Stem Cell Transplantation 83
null 83
PREDICTIVITY OF TEAR PARAMETERS IN THE ONSET OF OCULAR GRAFT VERSUS HOST DISEASE (GVHD) DRY EYE AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT). 79
null 75
Intrabone transplant provides full stemness of cord blood stem cells with fast hematopoietic recovery and low GVHD rate: results from a prospective study 73
Longitudinal tear protein changes correlate with ocular chronic gvhd development in allogeneic hematopoietic stem cell transplant patients 73
Inotuzumab ozogamicin and donor lymphocyte infusion is a safe and promising combination in relapsed acute lymphoblastic leukemia after allogeneic stem cell transplant 73
CAR+ extracellular vesicles predict ICANS in patients with B cell lymphomas treated with CD19-directed CAR T cells 66
Safety profile and impact on survival of tyrosine kinase inhibitors versus conventional therapy in relapse or refractory FLT3 positive acute myeloid leukemia patients 62
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters 61
Low doses ATLG as GvHD prophylaxis in allogeneic hematopoietic stem cell transplantation for lymphomas 61
Dry Eye Disease Is Already Present in Hematological Patients before Hematopoietic Stem Cell Transplantation 57
Molecular monitoring of acute myeloid leukemia associated with inv(16): Threshold of CBFβ/MYH11 transcript copy number above which relapse occurs and below which continuous complete remission is likely (multiple letters) [8] 55
Incidence, Risk Factors and Complications of Ocular Graft-Versus-Host Disease Following Hematopoietic Stem Cell Transplantation 54
Ribosomal DNA instability: An evolutionary conserved fuel for inflammaging 54
Transient Elastography Anticipates the Diagnosis of VOD/SOS after Adult Allogeneic Stem Cell Transplant: Results from a Prospective Study 51
Clinical Efficacy of Ponatinib in Philadelphia-Positive T-Cell Acute Lymphoblastic Leukemia with Extramedullary Involvement 49
Real World Evidence of CAR T-Cell Therapies for the Treatment of Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: A Monocentric Experience. 48
Allogeneic stem cell transplantation is capable of healing a case of bone marrow aplasia following CAR-T cell therapy in a lymphoma patient 47
A Multiparameter Prognostic Risk Score of Chronic Graft-versus-Host Disease Based on CXCL10 and Plasmacytoid Dendritic Cell Levels in the Peripheral Blood at 3 Months after Allogeneic Hematopoietic Stem Cell Transplantation 46
Questions concerning tyrosine kinase-inhibitor therapy and transplants in chronic phase chronic myeloid leukaemia 43
Liver Stiffness Measurement Allows Early Diagnosis of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Adult Patients Who Undergo Hematopoietic Stem Cell Transplantation: Results from a Monocentric Prospective Study 42
Positive HCMV DNAemia in stem cell recipients undergoing letermovir prophylaxis is expression of abortive infection 42
Economic evaluation of anti-CD19 CAR T-cell pathway for large B-cell lymphomas in the real-life setting: the experience of an Italian hub center in the first three years of activity 41
The role of extracellular DNA in COVID-19: Clues from inflamm-aging 40
Longitudinal Changes of Ocular Surface Microbiome in Patients Undergoing Hemopoietic Stem Cell Transplant (HSCT) 36
Intracranial pressure management in fulminant cerebral oedema after CAR T-cell therapy: Not all is lost! 35
The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma 33
Hepatosplenic T-cell non-Hodgkin lymphoma cured with tandem autologous and allogeneic stem cell transplantation 33
Erratum: Phase II study of a single pegfilgrastim injection as an adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients (Haematologica (2005) 90, (225-231). 28
Correction to: Primary vs. pre-emptive anti-seizure medication prophylaxis in anti-CD19 CAR T-cell therapy 27
Pixantrone as bridging therapy to allogeneic transplantation or in chimeric antigen receptor T‐cell pathway in patients with diffuse large B‐cell lymphoma 24
Axicabtagene ciloleucel treatment is more effective in primary mediastinal large B-cell lymphomas than in diffuse large B-cell lymphomas: the Italian CART-SIE study 24
Correction to: Fulminant cerebral edema following CAR T-cell therapy: case report and pathophysiological insights from literature review (Journal of Neurology, (2022), 269, 8, (4560-4563), 10.1007/s00415-022-11117-8) 22
CMV-RNAemia as new marker of active viral replication in transplant recipients 22
Outcome of early treatment of SARS-CoV-2 infection in patients with haematological disorders 20
Successful Bridging to Allogeneic Transplantation With Valemetostat in Two Refractory/relapsed Peripheral T-cell lymphoma patients 20
Primary vs. pre-emptive anti-seizure medication prophylaxis in anti-CD19 CAR T-cell therapy 20
Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study 19
Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma 15
Feasibility of CD19 CAR T-cell therapy in patients with cardiac lymphoma 13
Epigenetic age acceleration in hematopoietic stem cell transplantation 11
Factors influencing the perception of protective isolation in patients undergoing haematopoietic stem cell transplantation: A multicentre prospective study 5
Development and initial validation of a questionnaire to assess patients’ perception of protective isolation following haematopoietic stem cell transplantation 4
Totale 7.695
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.646
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.646
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020597 0 0 0 0 0 0 120 157 137 78 60 45
2020/2021791 129 44 16 22 36 45 7 52 60 48 57 275
2021/20221.418 78 36 73 152 96 46 49 119 84 143 331 211
2022/20231.931 216 282 106 250 125 151 56 103 301 41 194 106
2023/2024758 56 85 63 105 64 175 25 44 15 38 58 30
2024/20251.300 128 331 233 207 242 157 2 0 0 0 0 0
Totale 7.695